Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
6.53
+0.49 (8.11%)
At close: Aug 1, 2025, 4:00 PM
6.67
+0.14 (2.14%)
After-hours: Aug 1, 2025, 7:19 PM EDT
Revance Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $707.81 million as of August 1, 2025. Its market cap has decreased by -32.12% in one year.
Market Cap
707.81M
Enterprise Value
528.04M
1-Year Change
-32.12%
Ranking
Category
Stock Price
$6.53
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $707.81M, an increase of 352.84%. That is a compound annual growth rate of 42.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 707.81M | 113.25% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | 156.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.74B |
| Johnson & Johnson | 402.04B |
| AbbVie | 341.16B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 233.03B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 224.40B |
| Novo Nordisk | 221.96B |